Activation of p38 mitogen-activated protein kinase by oxidized LDL in vascular smooth muscle cells - Mediation via pertussis toxin-sensitive G proteins and association with oxidized LDL-induced cytotoxicity

被引:0
作者
Jing, Q
Xin, SM
Cheng, ZJ
Zhang, WB
Zhang, R
Qin, YW
Pei, G
机构
[1] Chinese Acad Sci, Shanghai Inst Cell Biol, Shanghai 200031, Peoples R China
[2] 2nd Mil Med Univ, Changhai Hosp, Dept Cardiol, Shanghai, Peoples R China
关键词
atherosclerosis; oxidized LDL; p38 mitogen-activated protein kinase; vascular smooth muscle; cytotoxicity;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oxidized low-density lipoproteins (oxLDL) have been shown to play a crucial role in atherosclerosis, but the underlying molecular mechanisms have not been fully understood. The present study showed that oxLDL strongly evoked phosphorylation and activation of p38 mitogen-activated protein kinase (MAPK) in rat vascular smooth muscle cells (VSMCs) in concentration- and time-dependent manners, reaching the maximal activation at 100 mu g/mL within 5 minutes. The results from immunofluorescence staining also revealed that p38 MAPK was activated by oxLDL in 5 minutes, and the activated p38 MAPK was translocated from cytoplasm to nucleus of VSMCs in 15 minutes. Activation of p38 MAPK by oxLDL was apparently not mediated by their classical scavenger receptors and was not affected by tyrosine kinase inhibitors. However, activation of p38 MAPK was effectively blocked by pretreatment with pertussis toxin and was significantly reduced by phospholipase C inhibitor U-73122. OxLDL also inhibited forskolin-stimulated cAMP accumulation and increased inositol phosphate formation. More interestingly, inhibition of p38 MAPK by its specific inhibitor SB203580 significantly blocked oxLDL-induced cytotoxicity (increased leakage of cytoplasmic lactate dehydrogenase to the culture medium, reduced [H-3]thymidine incorporation, and attenuated mitochondrial metabolism of tetrazolium salt, (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium), MTS) in VSMCs, and pretreatment with pertussis toxin also inhibited oxLDL-induced cytotoxicity. Taken together, our data clearly demonstrated that oxLDL effectively activated p38 MAPK in VSMCs, which was likely mediated via pertussis toxin-sensitive G proteins, and the p38 activation was functionally associated with oxLDL-induced cytotoxicity in VSMCs.
引用
收藏
页码:831 / 839
页数:9
相关论文
共 38 条
[1]   The sphingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation [J].
Auge, N ;
Andrieu, N ;
NegreSalvayre, A ;
Thiers, JC ;
Levade, T ;
Salvayre, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) :19251-19255
[2]   Oxidized low density lipoproteins stimulate galactosyltransferase activity, ras activation, p(44) mitogen activated protein kinase and c-fos expression in aortic smooth muscle cells [J].
Chatterjee, S ;
Bhunia, AK ;
Snowden, A ;
Han, H .
GLYCOBIOLOGY, 1997, 7 (05) :703-710
[3]   Selective interference of β-arrestin 1 with κ and δ but not μ opioid receptor G protein coupling [J].
Cheng, ZJ ;
Yu, QM ;
Wu, YL ;
Ma, L ;
Pei, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (38) :24328-24333
[4]   The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs) [J].
Clerk, A ;
Sugden, PH .
FEBS LETTERS, 1998, 426 (01) :93-96
[5]  
CONKLIN BR, 1992, J BIOL CHEM, V267, P31
[6]   SB-203580 IS A SPECIFIC INHIBITOR OF A MAP KINASE HOMOLOG WHICH IS STIMULATED BY CELLULAR STRESSES AND INTERLEUKIN-1 [J].
CUENDA, A ;
ROUSE, J ;
DOZA, YN ;
MEIER, R ;
COHEN, P ;
GALLAGHER, TF ;
YOUNG, PR ;
LEE, JC .
FEBS LETTERS, 1995, 364 (02) :229-233
[7]   Stimulation of mitogen activated protein kinase by LDL and oxLDL in human U-937 macrophage-like cells [J].
Deigner, HP ;
Claus, R .
FEBS LETTERS, 1996, 385 (03) :149-153
[8]   Stress-activated protein kinases in cardiovascular disease [J].
Force, T ;
Pombo, CM ;
Avruch, JA ;
Bonventre, JV ;
Kyriakis, JM .
CIRCULATION RESEARCH, 1996, 78 (06) :947-953
[9]   Growth factors and mitogen activated protein kinases [J].
Force, T ;
Bonventre, JV .
HYPERTENSION, 1998, 31 (01) :152-161
[10]  
FUKAI MU, 1998, J BIOL CHEM, V273, P15022